[Effect of berberine bisulfate on platelet hemostasis in thrombocytopenia patients].
The authors recommend berberine bisulfate for use as thrombocytopoiesis stimulator in thrombocytopenias as they have found secondary therapeutic property of this drug--to increase platelet count in patients with primary and secondary thrombocytopenia. The drug was given as monotherapy and in combined treatment 3 times a day for 15 days in a dose 5 mg 20 min before meals.
Chekalina
S I
SI
Umurzakova
R Z
RZ
Saliev
K K
KK
Abdurakhmanov
T R
TR
D000293:Adolescent; D000328:Adult; D000368:Aged; D001599:Berberine / Q000031:analogs & derivatives / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D010976:Platelet Count / Q000187:drug effects; D013921:Thrombocytopenia / Q000097:blood / Q000188:drug therapy*
D001599:Berberine
Vliianie berberina bisul'fata na trombotsitarnyĭ gemostaz u bol'nykh s trombotsitopeniiami.